Literature DB >> 16142447

[Salivary gland carcinomas Part II. Diagnosis and therapy].

S Lang1, N Rotter, A Lorenzen, S Ihrler, R Eckel, D Hölzel, G Rasp, B Wollenberg, K Sommer.   

Abstract

Salivary gland carcinomas comprise a rare group of malignant tumors which are difficult to diagnose and treat due to their histopathologic diversity, variable clinical course and anatomic location, particularly with respect to the facial nerve. The present paper summarizes important features of these tumors, including recent advances in their management, i.e., diagnosis, surgery of the primary tumor, neck dissection, radiation therapy, and updates risk factors, criteria of malignancy, and prognostic variables, taking into account the relevant literature. Additionally, the present paper highlights briefly the survival rates of patients suffering from salivary gland carcinomas. The present overview is divided into two parts: the first is focused on epidemiology, etiology, criteria of malignancy, prognostic factors, and tumor classification, while part II discusses the diagnosis and therapy of salivary gland carcinomas.

Entities:  

Mesh:

Year:  2005        PMID: 16142447     DOI: 10.1007/s00106-005-1294-2

Source DB:  PubMed          Journal:  HNO        ISSN: 0017-6192            Impact factor:   1.284


  50 in total

1.  Aspiration cytology of soft tissue and bone.

Authors:  A H Qizilbash
Journal:  Diagn Cytopathol       Date:  1985 Apr-Jun       Impact factor: 1.582

2.  [High-resolution real-time sonography in salivary gland diseases. II: Salivary gland tumors].

Authors:  H G Schroeder; W B Schwerk; T Eichhorn
Journal:  HNO       Date:  1985-11       Impact factor: 1.284

Review 3.  European results in neutron therapy of malignant salivary gland tumors.

Authors:  A Krüll; R Schwarz; R Engenhart; P Huber; A Lessel; H Koppe; A Favre; N Breteau; T Auberger
Journal:  Bull Cancer Radiother       Date:  1996

4.  Anticancer activity of docetaxel in murine salivary gland carcinoma.

Authors:  Marie P Piechocki; Fulvio Lonardo; John F Ensley; Tam Nguyen; Harold Kim; George H Yoo
Journal:  Clin Cancer Res       Date:  2002-03       Impact factor: 12.531

5.  Carcinoma of the parotid gland.

Authors:  Peter Zbären; Jonas Schüpbach; Michel Nuyens; Edouard Stauffer; Richard Greiner; Rudolf Häusler
Journal:  Am J Surg       Date:  2003-07       Impact factor: 2.565

Review 6.  New aspects in parotid gland surgery.

Authors:  Eberhard Stennert; Claus Wittekindt; Jens Peter Klussmann; Orlando Guntinas-Lichius
Journal:  Otolaryngol Pol       Date:  2004

7.  Malignant parotid tumors in 110 consecutive patients: treatment results and prognosis.

Authors:  D Pedersen; J Overgaard; H Søgaard; O Elbrønd; M Overgaard
Journal:  Laryngoscope       Date:  1992-09       Impact factor: 3.325

8.  Malignant tumors of major salivary gland origin. A matched-pair analysis of the role of combined surgery and postoperative radiotherapy.

Authors:  J G Armstrong; L B Harrison; R H Spiro; D E Fass; E W Strong; Z Y Fuks
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1990-03

9.  Prognostic variables in parotid gland cancer.

Authors:  R A Frankenthaler; M A Luna; S S Lee; K K Ang; R M Byers; O M Guillamondegui; P Wolf; H Goepfert
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1991-11

Review 10.  The facial nerve in the presence of a head and neck neoplasm: assessment and outcome after surgical management.

Authors:  Orlando Guntinas-Lichius
Journal:  Curr Opin Otolaryngol Head Neck Surg       Date:  2004-04       Impact factor: 2.064

View more
  3 in total

1.  [On the diagnosis and treatment of parotid gland tumors. Results of a nationwide survey of ENT hospitals in Germany].

Authors:  S F Preuss; O Guntinas-Lichius
Journal:  HNO       Date:  2006-11       Impact factor: 1.284

Review 2.  [Surgery for parotid gland cancer-controversial and proven aspects].

Authors:  Konstantinos Mantsopoulos; Heinrich Iro
Journal:  HNO       Date:  2022-05-17       Impact factor: 1.284

3.  [Treatment of salivary gland malignancies].

Authors:  Michael Formanek
Journal:  Wien Med Wochenschr       Date:  2008
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.